Search | Clinical Trials Finder

Independent directory Public ClinicalTrials.gov records United States

ClinicalTrials.gov public records Last synced Sep 10, 2026, 3:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 56 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Intervention: GI198745 Clear all

Conditions: Prostate Cancer
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 50 Years to 75 Years · Male only
Enrollment: 6,608 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Prostate Cancer
Interventions: Enzalutamide and Dutasteride or finasteride; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 65 Years to 99 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 2
States / cities: Rochester, New York • Milwaukee, Wisconsin

Conditions: Contraception
Interventions: Testosterone Enanthate, Dutasteride, placebo sesame oil; Drug · Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Prostate Cancer
Interventions: PCUR-101, Dutasteride 0.5 mg, Abiraterone and Prednisone; Drug
Lead sponsor: Pellficure Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Omaha, Nebraska

Conditions: Gonadotropin Deficiency
Interventions: Testosterone 1% Gel, Acyline, Dutasteride, Ketoconazole, HCG, placebo dutasteride, placebo ketoconazole; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 55 Years · Male only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Prostate Cancer
Interventions: ketoconazole, hydrocortisone, dutasteride, lapatinib; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older · Male only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Hypogonadism, Hypogonadism, Male
Interventions: Nanomilled testosterone, commercially available dutasteride, Nanomilled dutasteride; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2006
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Benign Prostatic Hyperplasia
Interventions: Tamsulosin; Drug
Lead sponsor: Siami, Paul F., M.D.; Other
Eligibility: 50 Years and older · Male only
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Evansville, Indiana

Conditions: Prostatic Hyperplasia
Interventions: FDC capsule of dutasteride and tamsulosin, Dutasteride soft gelatine capsule and tamsulosin HCl oral disintegrating tablet; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Prostate Cancer
Interventions: Enzalutamide, Leuprolide, Dutasteride; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: Boston, Massachusetts • Seattle, Washington

Conditions: Hypogonadism, Benign Prostatic Hyperplasia
Interventions: Dutasteride, Testosterone gel, Placebo dutasteride; Drug
Lead sponsor: University of Washington; Other
Eligibility: 50 Years and older · Male only
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Prostate Cancer
Interventions: Dutasteride, Placebo; Drug
Lead sponsor: University of Illinois at Chicago; Other
Eligibility: 50 Years to 75 Years · Male only
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Premenstrual Syndrome, PMS, Healthy, Depression
Interventions: Dutasteride, Placebo oral capsule; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 30 Years to 50 Years · Female only
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Interventions: dutasteride; Drug
Lead sponsor: Urology of Virginia; Other
Eligibility: 50 Years and older · Male only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 2
States / cities: Norfolk, Virginia • Virginia Beach, Virginia

Conditions: Prostate Cancer
Interventions: dutasteride; Drug
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older · Male only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2013
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Obesity, Insulin Resistance
Interventions: Anastrazole, Testosterone, Dutasteride, GnRH antagonist; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 24 Years to 51 Years · Male only
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 2
States / cities: San Diego, California

Conditions: Prostatic Hyperplasia
Interventions: Dutasteride; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 50 Years and older · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 11
States / cities: Long Beach, California • New Britain, Connecticut • Trumbull, Connecticut + 8 more

Conditions: Hypogonadism
Interventions: dutasteride, placebo; Drug
Lead sponsor: The Miriam Hospital; Other
Eligibility: 40 Years to 85 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Boston, Massachusetts • Providence, Rhode Island

Conditions: Nonmalignant Neoplasm, Prostate Cancer
Interventions: dutasteride; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Prostate Cancer
Interventions: dutasteride, placebo; Drug · Other
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Other
Eligibility: 18 Years to 80 Years · Male only
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Alcohol Use Disorder
Interventions: Dutasteride Capsules, Placebo Capsules; Drug
Lead sponsor: UConn Health; Other
Eligibility: 35 Years to 70 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Neoplasms, Prostate
Interventions: Dutasteride, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 50 Years to 75 Years · Male only
Enrollment: 8,231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 297
States / cities: Birmingham, Alabama • Homewood, Alabama • Huntsville, Alabama + 236 more

Conditions: Neoplasms, Prostate
Interventions: dutasteride; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 50 Years and older · Male only
Enrollment: 2,795 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 73
States / cities: Anchorage, Alaska • Phoenix, Arizona • Little Rock, Arkansas + 68 more

Conditions: Prostatic Hyperplasia
Interventions: Treatment sequence A, Treatment sequence B, Treatment sequence C, Treatment sequence D; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Evansville, Indiana • Austin, Texas